Plasma FABP7 concentrations also correlated with Positive and Negative Syndrome Scale clinical scores, particularly in severities of depression/anxiety, cognition, and positive symptoms of schizophrenia patients (Koga et al., 2021). This evidence concerns the gene FABP7 and schizophrenia.